A small biopharma stock has spiked 187% as retail traders cheer CEO's roadmap for drug development following Nasdaq listing

Nastasic/Getty Images
Pharmacyte Biotech Inc. spiked 187% Wednesday as investors cheered on the CEO's vision for the company following its Nasdaq debut.Users on Stocktwits commented that the stock will go "to the moon."
The biopharma company's CEO said its recent Nasdaq listing will help improve liquidity and elevate its public profile.Sign up here for our daily newsletter, 10 Things Before the Opening Bell.
Pharmacyte Biotech Inc. spiked 187% to as high as $9.84 per share Wednesday as investors